Aurora Cannabis Inc. (ACB)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aurora Cannabis Inc. ("Aurora " or the "Company") (NYSE: ACB). The investigation concerns whether Aurora and certain of its officers and/or directors have violated federal securities laws.
On September 8, 2020, Aurora issued a press release “announc[ing] an update on its business operations along with certain unaudited preliminary fiscal fourth quarter 2020 results.” Among other things, Aurora announced that the Company expected to record up to $1.8 billion in goodwill impairment charges in the fourth quarter of 2020. In a separate announcement that same day, Aurora announced the appointment of Miguel Martin as the Company’s new Chief Executive Officer. On this news, Aurora’s stock price fell $0.99 per share, or 11.63%, to close at $7.52 per share on September 8, 2020.
If you are aware of any facts relating to this investigation, or purchased Aurora shares, you can assist this investigation by contacting the firm. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.